Overview

Sugammadex and Cognitive Function

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Post operative cognitive dysfunction (POCD) is recognized as a frequent complication after both cardiac and non cardiac surgery, affecting approximately 1/3 of the patients. The aim of this study is to examine the possible effect of the novel reversal agent sugammadex versus neostigmine/ atropine combination on cognitive function of adult patients after elective surgery during the early post operative period as well as at discharge.
Phase:
N/A
Details
Lead Sponsor:
Attikon Hospital
Treatments:
Atropine
Neostigmine